drugset / Trial / NCT00658736
Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis
Phase 3
Completed
40 enrolled
The Cleveland Clinic
American Society for Gastrointestinal Endoscopy · collabTAP Pharmaceutical Products Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a triple-blind, parallel group, randomized controlled trial to assess the benefit of triamcinolone injection as a therapeutic measure for control of chronic pancreatitis pain. The treatment group will undergo EUS-CPB with bupivicaine plus triamcinolone ("therapeutic block"). There control group will undergo EUS-CPB with bupivicaine alone ("diagnostic block").
Timeline
- Start
- 2008-03
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triamcinolone | Other / unclassified | — | Other |
| Comparator | Bupivacaine | Other / unclassified | — | Other |